Current stock page

Financial Data

ESTA Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - DevicesScore data as of Nov 18, 2026

ESTAEstablishment Labs Holdings Inc.

Healthcare / Medical - Devices

Low Priority

In Line With Peers

BearishEdge 4/10
$70.80+$1.29 (+1.86%)

Latest quote

  • Momentum
    58
  • Value
    32
  • Quality
    47
  • Risk resilience
    47
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

Latest Quarter at a Glance

Quarter ended Sep 30, 2026, compared with the same quarter a year earlier.

Revenue
$71.99M
+33.9% YoY
Net income
-$10.71M
+3.9% YoY
Free cash flow
$6.81M
+151.6% YoY
Operating margin
-3.6%
+3.8 pts YoY

Quarterly Financial Statements

Updated Nov 19, 2026.

ESTA, last 8 quarters. YoY compares the latest quarter with the same quarter a year earlier.

Income statement
Income statement, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Revenue+33.9%$72M$68M$60M$65M$54M$51M$41M$45M
Gross profit+31.9%$50M$48M$42M$46M$38M$35M$28M$30M
Operating income+34.9%−$3M−$4M−$7M−$4M−$4M−$14M−$17M−$19M
Net income+3.9%−$11M−$12M−$13M−$3M−$11M−$17M−$21M−$35M
EPS (diluted)+7.9%−$0.35−$0.39−$0.45−$0.09−$0.38−$0.56−$0.70−$1.19
Gross margin−1.0 pts69.1%70.6%70.7%70.5%70.1%68.8%67.2%68.5%
Operating margin+3.8 pts-3.6%-6.4%-10.9%-6.1%-7.5%-27.5%-41.0%-41.9%
Net margin+5.8 pts-14.9%-17.4%-22.3%-4.0%-20.7%-32.3%-50.1%-77.6%
Cash flow
Cash flow, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Operating cash flow+168.4%$8M−$17M−$4M−$556K−$11M−$19M−$21M−$21M
Capital expenditure+54.8%−$885K−$4M−$2M−$2M−$2M−$2M−$753K−$2M
Free cash flow+151.6%$7M−$20M−$6M−$2M−$13M−$20M−$21M−$23M
Free cash flow margin+34.0 pts9.5%-29.8%-10.5%-3.8%-24.6%-39.6%-51.9%-50.6%
Balance sheet
Balance sheet, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Total assets+5.9%$359M$352M$351M$357M$339M$330M$333M$347M
Total liabilities+6.4%$343M$330M$336M$334M$323M$307M$295M$294M
Shareholders' equity−4.7%$16M$22M$15M$24M$16M$23M$39M$53M
Total debt+3.2%$270M$264M$264M$264M$261M$231M$226M$225M
Cash and equivalents+7.3%$76M$71M$68M$76M$71M$55M$69M$90M
Valuation and ratios
Valuation and ratios, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
P/B ratio+15.83133.50107.93143.8199.00117.6746.5625.9423.37
Return on equity−241.5 pts-246.6%-180.0%-295.9%-216.9%-5.1%-3.9%-231.1%-159.3%
Debt to equity+1.3217.2812.2017.8611.2315.9610.155.854.24
Free cash flow yield+3.0 pts-1.1%-1.8%-2.0%-2.5%-4.0%-7.4%-7.7%-5.9%

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
P/E ratio-54.38x
P/B ratio135.64x
Revenue growth (YoY)33.86%
EPS growth (YoY)7.89%
Gross margin70.18%
Operating margin-6.57%
ROE-203.65%
ROIC-4.96%
Debt to equity17.28
FCF yield-1.06%

As of Nov 18, 2026

Technical indicators
MetricValue
Close
As of Nov 18, 2026
$70.80
Volume
As of Nov 13, 2026
367,354
RSI (14)
As of Nov 13, 2026
58.64
MACD
As of Nov 13, 2026
1.16
MACD signal
As of Nov 13, 2026
0.31
MACD histogram
As of Nov 13, 2026
0.85
ADX (14)
As of Nov 13, 2026
19
SMA (50)
As of Nov 13, 2026
$66.04
SMA (200)
As of Nov 13, 2026
$72.39
ATR (14)
As of Nov 13, 2026
$4.14
Historical volatility (annualized)
As of Nov 13, 2026
61.33%
Volume (20-day average)
As of Nov 13, 2026
517,587
Risk measures
MetricValue
Resilience score47/100
Beta1.5
Annual volatility49.89%
Max drawdown-39.49%
Sharpe ratio0.35
VaR (95%, 1-day)-4.73%

As of Nov 18, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

ESTA Financial Data FAQ

What is Establishment Labs Holdings Inc.'s revenue?

Establishment Labs Holdings Inc.'s revenue is one of the core financial data points for ESTA. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Establishment Labs Holdings Inc.'s revenue growing?

Revenue growth shows whether Establishment Labs Holdings Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is ESTA's EPS?

ESTA's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Establishment Labs Holdings Inc.'s net income?

Establishment Labs Holdings Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Establishment Labs Holdings Inc. generate?

Free cash flow shows how much cash Establishment Labs Holdings Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Establishment Labs Holdings Inc. have?

Cash and debt help frame ESTA's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.